Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma

26 Nov 2015

Abstract excerpt

The natural killer group 2 member D (NKG2D) receptor and its ligands are important mediators of immune responses to tumors. NKG2D ligands are overexpressed in several malignant tumor types; however, the prognostic value of these ligands is unclear. Here, we aimed to elucidate the role of NKG2D ligands in extrahepatic cholangiocarcinoma (EHCC). We therefore investigated the expression of the NKG2D receptor and its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune Cell Function and Interaction
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26608587
DOI: 10.1111/cas.12853

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinomaPMID 26608587Read ↗

Advances in NKG2D ligand recognition and responses by NK cellsSemantic proximity Read ↗

NKG2D Ligands–Critical Targets for Cancer Immune Escape and TherapySemantic proximity Read ↗

NKG2D Ligands in Tumor Immunity: Two Sides of a CoinSemantic proximity Read ↗

MICA SNPs and the NKG2D system in virus-induced HCC.Semantic proximity Read ↗

NKG2D signaling in cancer immunosurveillanceSemantic proximity Read ↗

Analysis of the Expression and Prognosis for Leukocyte Immunoglobulin-Like Receptor Subfamily B in Human Liver CancerSemantic proximity Read ↗

The Role and Regulation of the NKG2D/NKG2D Ligand System in CancerSemantic proximity Read ↗

Genetics, genomics, and evolutionary biology of NKG2D ligands.Semantic proximity Read ↗

NKG2D Receptor and Its Ligands in Host DefenseSemantic proximity Read ↗

Regulation of Ligands for the NKG2D Activating ReceptorSemantic proximity Read ↗

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for ImmunoeditingSemantic proximity Read ↗

Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.